Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

4 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 2

4(50.0%)

Phase 3

3(37.5%)

Phase 4

1(12.5%)

8Total

Phase 2(4)

Phase 3(3)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT04146376Recruiting

Von Willebrand Factor in Pregnancy (VIP) Study

Role: collaborator

NCT05239858Recruiting

International Wilson's Disease Patient Registry (iWilson Registry)

Role: collaborator

NCT06920771Phase 3Active Not Recruiting

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)

Role: collaborator

NCT04744207Phase 2Completed

A Study to Investigate Safety of GS-248 and Efficacy on Raynauds' Phenomenon in Systemic Sclerosis

Role: collaborator

NCT00977483Phase 3Completed

Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)

Role: collaborator

NCT03697265Phase 2Completed

A Study of Efficacy and Safety of Sepranolone (UC1010) in Patients With Premenstrual Dysphoric Disorder (PMDD)

Role: collaborator

NCT02515838Phase 2Completed

Sevuparin Infusion for the Management of Acute VOC in Subjects With SCD